Corrigendum to ''Sotatercept use in a patient with pulmonary arterial hypertension undergoing lung transplantation'' [JHLT Open (2025) 100213]

Affiliations

¹ Ohio State University, Department of Internal Medicine, Division of Pulmonary Critical Care and Sleep Medicine, Davis Heart and Lung Institute, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio.
² Ohio State University, College of Pharmacy, Columbus, Ohio.
³ Ohio State University, Department of Surgery, Division of Cardiac Surgery, Columbus, Ohio.
⁴ Ohio State University, Department of Internal Medicine, Division of Cardiovascular Medicine, Columbus, Ohio.

Published Erratum

Justin P Rosenheck et al. JHLT Open. 2025.

. 2025 Nov 5:10:100430.

doi: 10.1016/j.jhlto.2025.100430. eCollection 2025 Nov.

¹ Ohio State University, Department of Internal Medicine, Division of Pulmonary Critical Care and Sleep Medicine, Davis Heart and Lung Institute, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio.
² Ohio State University, College of Pharmacy, Columbus, Ohio.
³ Ohio State University, Department of Surgery, Division of Cardiac Surgery, Columbus, Ohio.
⁴ Ohio State University, Department of Internal Medicine, Division of Cardiovascular Medicine, Columbus, Ohio.

Abstract

[This corrects the article DOI: 10.1016/j.jhlto.2025.100213.].

Sotatercept Use in a Patient with Pulmonary Arterial Hypertension Undergoing Lung Transplantation.
Rosenheck JP, Goyal K, Fallah T, Burcham P, Choi K, Henn M, Homsy E, Visovatti S, Franco V. Rosenheck JP, et al. JHLT Open. 2025 Jan 14;8:100213. doi: 10.1016/j.jhlto.2025.100213. eCollection 2025 May. JHLT Open. 2025. PMID: 40144721 Free PMC article.